Literature DB >> 12112619

Inverse 15N-metabolic labeling/mass spectrometry for comparative proteomics and rapid identification of protein markers/targets.

Y Karen Wang1, Zhixiang Ma, Douglas F Quinn, Emil W Fu.   

Abstract

The inverse labeling/mass spectrometry strategy has been applied to protein metabolic (15)N labeling for gel-free proteomics to achieve the rapid identification of protein markers/targets. Inverse labeling involves culturing both the perturbed (by disease or by a drug treatment) and control samples each in two separate pools of normal and (15)N-enriched culture media such that four pools are produced as opposed to two in a conventional labeling approach. The inverse labeling is then achieved by combining the normal (14)N-control with the (15)N-perturbed sample, and the (15)N-control with the (14)N-perturbed sample. Both mixtures are then proteolyzed and analyzed by mass spectrometry (coupled with on-line or off-line separation). Inverse labeling overcomes difficulties associated with protein metabolic labeling with regard to isotopic peak correlation and data interpretation in the single-experiment approach (due to the non-predictable/variable mass difference). When two data sets from inverse labeling are compared, proteins of differential expression are readily recognized by a characteristic inverse labeling pattern or apparent qualitative mass shifts between the two inverse labeling analyses. MS/MS fragmentation data provide further confirmation and are subsequently used to search protein databases for protein identification. The methodology has been applied successfully to two model systems in this study. Utilizing the inverse labeling strategy, one can use any mass spectrometer of standard unit resolution, and acquire only the minimum, essential data to achieve the rapid and unambiguous identification of differentially expressed protein markers/targets. The strategy permits quick focus on the signals of differentially expressed proteins. It eliminates the detection ambiguities caused by the dynamic range of detection. Finally, inverse labeling enables the detection of covalent changes of proteins responding to a perturbation that one might fail to distinguish with a conventional labeling experiment. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112619     DOI: 10.1002/rcm.725

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.

Authors:  Rodrigo D A M Alves; Marco Eijken; Karel Bezstarosti; Jeroen A A Demmers; Johannes P T M van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2013-06-17       Impact factor: 5.911

2.  Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer.

Authors:  Marcus Bantscheff; Markus Boesche; Dirk Eberhard; Toby Matthieson; Gavain Sweetman; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2008-05-29       Impact factor: 5.911

3.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

4.  Application of Parallel Reaction Monitoring in 15N Labeled Samples for Quantification.

Authors:  Andres V Reyes; Ruben Shrestha; Peter R Baker; Robert J Chalkley; Shou-Ling Xu
Journal:  Front Plant Sci       Date:  2022-05-03       Impact factor: 6.627

5.  15N Metabolic Labeling Quantification Workflow in Arabidopsis Using Protein Prospector.

Authors:  Ruben Shrestha; Andres V Reyes; Peter R Baker; Zhi-Yong Wang; Robert J Chalkley; Shou-Ling Xu
Journal:  Front Plant Sci       Date:  2022-02-15       Impact factor: 5.753

6.  iTRAQ-based quantitative proteomics analysis of immune thrombocytopenia patients before and after Qishunbaolier treatment.

Authors:  Yanbo Wang; Shuanglian Wang; Cuiqin Gong; Haihua Bai
Journal:  Rapid Commun Mass Spectrom       Date:  2021-02-15       Impact factor: 2.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.